These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9257877

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A, Wada H, Takagi M, Yamamuro M, Mukai K, Nakasaki T, Shimura M, Hiyoyama K, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Shiku H.
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M, Nakabayashi T, Iuchi K, Ishikawa T, Kaseno K, Yoshida T, Asakura H, Matsuda T.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S, Letsch R, Ehlers R, Walter T, Kazmaier S, Helber U, Hoffmeister HM.
    Thromb Res; 2002 Apr 15; 106(2):113-9. PubMed ID: 12182909
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R, Wada H, Sakakura M, Mori Y, Nakasaki T, Okugawa Y, Gabazza EC, Hayashi T, Nishioka J, Suzuki K, Shiku H, Nobori T.
    Am J Hematol; 2000 Sep 15; 65(1):35-40. PubMed ID: 10936861
    [Abstract] [Full Text] [Related]

  • 8. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K, Matsuo T.
    Atherosclerosis; 1993 Nov 15; 103(2):131-8. PubMed ID: 8292090
    [Abstract] [Full Text] [Related]

  • 9. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K, Fujimaki M.
    Nihon Rinsho; 1993 Jan 15; 51(1):37-42. PubMed ID: 8433526
    [Abstract] [Full Text] [Related]

  • 10. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y, Wada H, Yamamuro M, Inoue A, Shimura M, Hiyoyama K, Gabazza EC, Isaka N, Shiku H, Takeya H, Suzuki K, Kumeda K, Kato H, Nakano T.
    Am J Hematol; 1999 Aug 15; 61(4):238-42. PubMed ID: 10440909
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T.
    Clin Appl Thromb Hemost; 2001 Jul 15; 7(3):229-33. PubMed ID: 11441985
    [Abstract] [Full Text] [Related]

  • 12. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
    Mustonen P, Lepäntalo M, Lassila R.
    Arterioscler Thromb Vasc Biol; 1998 Feb 15; 18(2):244-9. PubMed ID: 9484989
    [Abstract] [Full Text] [Related]

  • 13. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J, Munkvad S, Leebeek FW, Kluft C, Jespersen J.
    Coron Artery Dis; 1993 Apr 15; 4(4):371-7. PubMed ID: 8261210
    [Abstract] [Full Text] [Related]

  • 14. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
    Gyöngyösi M, Glogar D, Weidinger F, Domanovits H, Laggner A, Wojta J, Zorn G, Iordanova N, Huber K.
    Am Heart J; 2004 Jan 15; 147(1):158-64. PubMed ID: 14691435
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 15; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A.
    Am Heart J; 1997 Apr 15; 133(4):387-92. PubMed ID: 9124158
    [Abstract] [Full Text] [Related]

  • 19. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T.
    Am J Hematol; 1993 Oct 15; 44(2):101-5. PubMed ID: 8266913
    [Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism.
    Flores J, García-Avello A, Flores VM, Navarro JL, Canseco F, Pérez-Rodríguez E.
    Arch Pathol Lab Med; 2003 Mar 15; 127(3):310-5. PubMed ID: 12653574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.